News & Analysis on Clinical Trial Services & Contract Research And Development
People on the move
UDG Healthcare and Ashfield
By Melissa Fassbender
- Last updated on
UDG Healthcare has announced that following Philip Toomey’s planned retirement as a non-executive director of UDG, Chris Brinsmead will become the senior independent director.
Additionally, Nancy Miller-Rich will become a member of UDG’s Risk, Investment and Financing Committee.
UDG’s Ashfield division also made changes this month, appointing Greg Flynn to oversee US operations of commercial, clinical, medical information, pharmacovigilance and market access.
Flynn was previously regional president in Japan and representative director of CMIC Ashfield. With his departure from this role, Mick O’Leary will take over the roles of regional president in Japan and will lead the CMIC Ashfield joint venture. Mick was previously the Managing Director for Ashfield Ireland.